Strides Pharma Science Limited (BOM:532531)

India · Delayed Price · Currency is INR

865.60

-12.00 (-1.37%)

At close: Feb 12, 2026

Revenue by Product

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Pharmaceutical	40.51B
Pharmaceutical Growth	9.83%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
North America	21.48B
North America Growth	11.50%
Europe	9.20B
Europe Growth	9.87%
Africa	3.91B
Africa Growth	-13.30%
Australia	3.71B
Australia Growth	19.11%
Global	1.60B
Global Growth	98.35%
India	331.28M
India Growth	51.53%
Asia (excluding India)	172.38M
Asia (excluding India) Growth	-62.57%
Other	116.12M
Other Growth	-19.33%